ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Tuesday reported fourth-quarter net income of $450,000, after reporting a loss in the same period a year earlier.
On a per-share basis, the Alachua, Florida-based company said it had net income of 1 cent. Earnings, adjusted for stock option expense, were 8 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.
The regenerative medicine company posted revenue of $49.4 million in the period.
For the year, the company reported that its loss narrowed to $10 million, or 23 cents per share. Revenue was reported as $187.3 million.
AxoGen shares have increased slightly more than 9% since the beginning of the year. The stock has increased 76% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXGN at https://www.zacks.com/ap/AXGN
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.